J Nephropathol. 2017;6(2): 81-89. doi: 10.15171/jnp.2017.14
PMID: 28491858        PMCID: PMC5418075

Original Article

Clinical outcomes and quality of life in hemodialysis diabetic patients versus non-diabetics

Tayebeh Soleymanian 1 * , Zeinab Kokabeh 1, Rozita Ramaghi 2, Alireza Mahjoub 2, Hassan Argani 3

Cited by CrossRef: 8

1- Mancin S, Alterchi E, Finazzi S, Badalamenti S. Assistenza infermieristica e wound care nel paziente affetto da insufficienza renale cronica in trattamento dialitico. Ital J Wound Care. 2021;5(1) [Crossref]
2- Lin M, Lin S, Kuo L, Chen T, Chen C, Yu P, Tsai Y, Hsu W. Chronic Kidney Disease Is Associated with High Mortality Risk in Patients with Diabetes after Primary Shoulder Arthroplasty: A Nationwide Population-Based Cohort Study. Diagnostics. 2021;11(5):822 [Crossref]
3- Bao L, Li J, Zha D, Zhang L, Gao P, Yao T, Wu X. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathways. International Immunopharmacology. 2018;54:245 [Crossref]
4- Iryaningrum M, Supriyadi R, Lawrensia S, Henrina J, M. Soetedjo N. Diabetes and mortality among patients with chronic kidney disease and COVID-19: A systematic review, meta-analysis, and meta-regression. Indian J Nephrol. 2022;32(4):327 [Crossref]
5- Vanorio-Vega I, Constantinou P, Tuppin P, Couchoud C. Additional cost of end-stage kidney disease in diabetic patients according to renal replacement therapy modality: a systematic review. Ren Replace Ther. 2021;7(1) [Crossref]
6- Su X, Lv L, Li Y, Fang R, Yang R, Li C, Li T, Zhu D, Li X, Zhou Y, Shan H, Liang H. lncRNA MIRF Promotes Cardiac Apoptosis through the miR-26a-Bak1 Axis. Molecular Therapy - Nucleic Acids. 2020;20:841 [Crossref]
7- Alalawi F, Bashier A. Management of diabetes mellitus in dialysis patients: Obstacles and challenges. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(3):1025 [Crossref]
8- Ou S, Chen H, Fang N, Yin C, Chen C, Chen J. Effect of anti-diabetic drugs in dialysis patients with diabetes: a nationwide retrospective cohort study. Cardiovasc Diabetol. 2021;20(1) [Crossref]
9- Huang P, Chen T, Lin Y, Lin S, Kuo L, Chen C, Yu P, Hsu W. Chronic Kidney Disease Worsens Health Outcomes in Diabetic Patients After Hip Fracture Surgery: An Asian Nationwide Population‐Based Cohort Study. Journal of Bone and Mineral Research. 2019;34(5):849 [Crossref]
10- Glyde M, Keane D, Dye L, Sutherland E. Patients’ perceptions of their experience, control and knowledge of fluid management when receiving haemodialysis. Journal of Renal Care. 2019;45(2):83 [Crossref]
11- Martin W, White J, López-Hernández F, Docherty N, le Roux C. Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?. Front Endocrinol. 2020;11 [Crossref]
12- Attique H, Phachu D, Loza A, Campbell W, Hammer E, Elali I. Diabetic nephropathy in pregnancy: Report of two cases progressing to end-stage renal disease within one year postpartum. Case Reports in Women's Health. 2021;31:e00326 [Crossref]
13- Teles F, Amorim de Albuquerque A, Freitas Guedes Lins I, Carvalho Medrado P, Falcão Pedrosa Costa A. Quality of life and depression in haemodialysis patients. Psychology, Health & Medicine. 2018;23(9):1069 [Crossref]
14- Coimbra S, Reis F, Nunes S, Viana S, Valente M, Rocha S, Catarino C, Rocha-Pereira P, Bronze-da-Rocha E, Sameiro-Faria M, Oliveira J, Madureira J, Fernandes J, Miranda V, Belo L, Santos-Silva A. The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index. Oxidative Medicine and Cellular Longevity. 2019;2019:1 [Crossref]